Intervention adherence, engagement and tool utilization in the breast cancer weight loss (BWEL) trial by race and ethnicity (Alliance A011401).
1586 Background: Black and Hispanic breast cancer (BC) survivors have a higher prevalence of obesity and experience less success with weight loss interventions (WLI) than White BC survivors. The BWEL trial (Alliance A011401; NCT02750826) is a phase III randomized trial evaluating the impact of a 2-year telephone-based WLI on invasive disease-free survival in participants (pts) with stage II-III HER2-negative BC and a BMI ≥ 27 kg/m 2 . At 12-months, the WLI induced significant weight loss across demographic factors, including race and ethnicity. However, Black and Hispanic pts lost less weight and completed fewer calls than White pts. Here, we evaluate intervention adherence, engagement and tool utilization in BWEL pts by race and ethnicity. Methods: BWEL randomized pts to a WLI plus health education (HE) or HE alone. WLI pts received semi-structured telephone-based health coaching, delivered in English or Spanish, and received an activity monitor and wireless scale. Pts self-reported race and ethnicity. Mean values for call duration, call density (time to complete the initial 12-week intensive intervention phase), intervention attrition, and frequency of Fitbit use and weight tracking over 12-months were compared by race and ethnicity, comparing least squares means with Tukey-Kramer adjustment for multiple comparisons with adjusted p-values. Results: Of 3181 pts randomized to the study between 08/2016 and 02/2021, 1591 pts were allocated to the WLI arm. 80.5% of pts were White, 12.8% Black, and 7.1% Hispanic. Average BMI was 34.5 (±5.7) kg/m2. Compared to White pts, Black pts had fewer days of Fitbit usage (113.6 vs. 159.8, p<0.0001) and weight tracking (77.9 vs. 135.6 days, p< 0.0001). Hispanic pts had fewer days of Fitbit usage (108.8 vs. 154.9, p= 0.001) and weight tracking (87 vs. 129.5 days, p=0.0002) compared to non-Hispanic pts. There were no differences in attrition rate, average call duration, or call density by race or ethnicity. Conclusions: In a phase III WLI trial, engagement with tools designed to support weight loss was significantly lower in Black and Hispanic pts. Future work is needed to explore ways to enhance engagement and improve weight loss outcomes for racial and ethnic minority pts. Support: U10CA180821, U10CA180882, UG1CA189823; https://acknowledgments.alliancefound.org . Clinical trial information: NCT02750826 . Measure of engagement Race Ethnicity WhiteN=1281 BlackN=204 p-value Non-HispanicN=1459 HispanicN=113 p-value Withdrew from intervention n (%) 58 (4.5%) 13 (6.4%) 0.56 70 (4.8%) 6 (5.3%) 0.51 Call Duration (min)Mean (SD) 34.5 (7.6) 34.6 (9.1) 0.99 34.6 (7.8) 33.3 (7.9) 0.25 Call density(weeks)Mean (SD) 14.2 (7.2) 14.2 (8.8) 0.99 14.2 (7.3) 14.2 (9.7) 0.99 Days of Fitbit UseMean (SD) 159.8 (132.2) 113.6 (124.7) < 0.0001 154.9 (131.8) 108.8 (125.7) 0.001 Days of weight trackingMean (SD) 135.6 (109.5) 77.9 (87.5) < 0.0001 129.5 (108.8) 87 (96.5) 0.0002
Authors
- Vanessa Bernstein (ORCID: https://orcid.org/0000-0001-6216-8376)
- Thomas A. Wadden (ORCID: https://orcid.org/0000-0002-0438-4609)
- Electra D. Paskett (ORCID: https://orcid.org/0000-0002-8247-8299)
- Patricia A. Spears (ORCID: https://orcid.org/0000-0003-1167-0387)
- Jennifer A. Ligibel (ORCID: https://orcid.org/0000-0002-0633-3151)
- Ann H. Partridge (ORCID: https://orcid.org/0000-0002-4722-4824)
- Julia R. White (ORCID: https://orcid.org/0000-0001-6624-5631)
- Judith O. Hopkins (ORCID: https://orcid.org/0000-0002-9829-1242)
- Linda M. Delahanty (ORCID: https://orcid.org/0000-0002-1525-3559)
- Lisa A. Carey (ORCID: https://orcid.org/0000-0003-2388-4649)
- Linda McCall
- Pamela J. Goodwin (ORCID: https://orcid.org/0000-0003-2637-6906)
- Eric P. Winer (ORCID: https://orcid.org/0000-0002-8819-1723)
- Erica L. Mayer (ORCID: https://orcid.org/0000-0001-5430-8957)
- Karla V. Ballman (ORCID: https://orcid.org/0000-0002-4492-0357)
- Ashley Odai-Afotey
- Anna Weiss
- Dawn L. Hershman (ORCID: https://orcid.org/0000-0001-8807-153X)
- Chao Cao (ORCID: https://orcid.org/0000-0002-0455-1171)
- Vered Stearns
Institutions
- University of North Carolina at Chapel Hill (US)
- BC Cancer Agency (CA)
- Mount Sinai Hospital (CA)
- Mayo Clinic (US)
- Harvard University (US)
- Cornell University (US)
- Columbia University Irving Medical Center (US)
- Alliance for Clinical Trials in Oncology (US)
- Yale Cancer Center (US)
- The Ohio State University Wexner Medical Center (US)
- Massachusetts General Hospital (US)
- The University of Kansas Cancer Center (US)
- Southeast Clinical Oncology Research Consortium (US)
- Dana-Farber Cancer Institute (US)
- University of Kansas Medical Center (US)
- Weill Cornell Medicine (US)
- University of Rochester (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1200/jco.2025.43.16_suppl.1586
- Primary Topic
- Nutrition, Genetics, and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00